The EksoNR is a next-generation EksoGT exoskeleton device developed by Ekso Bionics Holdings Inc to aid the neurorehabilitation of patients recovering from stroke and spinal cord injury, and to help them learn to walk again with a more natural gait.
Among the EksoNR’s new features and enhancements is EksoView, a new touchscreen controller that allows therapists to intuitively adapt assistance to challenge patients using real-time feedback and perform outcome measures during use.
Held in the palm of a therapists’ hand, EksoView provides visualization of various exercises beyond gait training, such as balancing, squatting from sit-to-stand positioning, lifting one leg, or standing in place, to actively engage patients and enhance the use of these beneficial features.
Another feature is the optimized SmartAssist software, developed to enable EksoNR to have a smoother and more natural gait path when transitioning between steps.
SmartAssist also gives gait symmetry and posture feedback and allows therapists to track patient progress with the upgraded EksoPulse, a cloud-based analytics solution. EksoPulse now uses rehabilitation data to generate insightful metrics and graphs for therapists and administrators to monitor patient progress and outcomes, Ekso Bionics notes in a media release.
“Ekso Bionics is committed to developing the latest exoskeleton advances for rehabilitation. We continue to innovate to ensure physical therapists have access to the latest tools to deliver better patient outcomes and superior care in neurorehabilitation,” says Jack Peurach, chief executive officer and president of Ekso Bionics, in the release.
“EksoNR is a full neurorehabilitation tool that is effective, intuitive, and differentiating. There is an increasing demand for adoption, as our technology sets rehabilitation centers apart,” he adds.
EksoNR is cleared by the US Federal Drug Administration for stroke and spinal cord injury rehabilitation. The device is also CE-marked and available in Europe.
Ekso Bionics will begin taking orders for EksoNR immediately. Existing customers will have the option to upgrade, the release continues.
[Source: Ekso Bionics]